On 31 January 2022, the U.S. Food and Drug Administration, in its News Release: Coronavirus (COVID-19) Update: FDA Takes Key Action by Approving Second COVID-19 Vaccine, approved a vaccine for the prevention of COVID-19 in individuals 18 years of age and older. It accomplished this by simply changing the name of the Moderna COVID-19 Vaccine, which has had an emergency use authorization (EUA) since December 18, 2020, to SPIKEVAX.
Fake SPIKEVAX Vaccine Approved by FDA
Fake SPIKEVAX Vaccine Approved by FDA
Fake SPIKEVAX Vaccine Approved by FDA
On 31 January 2022, the U.S. Food and Drug Administration, in its News Release: Coronavirus (COVID-19) Update: FDA Takes Key Action by Approving Second COVID-19 Vaccine, approved a vaccine for the prevention of COVID-19 in individuals 18 years of age and older. It accomplished this by simply changing the name of the Moderna COVID-19 Vaccine, which has had an emergency use authorization (EUA) since December 18, 2020, to SPIKEVAX.